Organicell Regenerative Medicine, Inc. reported earnings results for the first quarter ended January 31, 2022. For the first quarter, the company reported sales was USD 1.6 million compared to USD 1.37 million a year ago. Net loss was USD 1.69 million compared to USD 8.15 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.72 USD | +3.61% | -7.03% | +68.63% |
06-03 | Zeo Scientifix, Inc. Announces Management Changes | CI |
06-03 | Zeo Scientifix, Inc. Announces Chief Executive Officer Changes | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+68.63% | 10.17M | |
+26.36% | 76.86B | |
-1.67% | 24.12B | |
+5.87% | 8.71B | |
+11.36% | 8.57B | |
-23.95% | 7.67B | |
+15.02% | 5.25B | |
+1.51% | 4.12B | |
-8.25% | 3.88B | |
+17.02% | 3.55B |
- Stock Market
- Equities
- ZEOX Stock
- News Zeo ScientifiX, Inc.
- Organicell Regenerative Medicine, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2022